share_log

Needham Reiterates Buy on Harmony Biosciences, Maintains $50 Price Target

Needham Reiterates Buy on Harmony Biosciences, Maintains $50 Price Target

尼德姆重申買入Harmony Biosciences,維持50美元的目標股價
Moomoo 24/7 ·  04/09 06:24

Needham analyst Ami Fadia reiterates Harmony Biosciences (NASDAQ:HRMY) with a Buy and maintains $50 price target.

Needham分析師阿米·法迪亞重申Harmony Biosciences(納斯達克股票代碼:HRMY)的買入並維持50美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論